Clinical Trial Management Services in India | Voxtur Clinical Research
Accelerate your clinical drug development timeline with full-spectrum operational excellence. Voxtur Clinical Research delivers turnkey clinical trial management services in India, combining rapid nationwide site initiation, access to diverse treatment-naive patient cohorts, proactive CDSCO regulatory navigation, and unwavering ICH-GCP compliance across Phase I–IV studies.
Conducting multi-center clinical trials in emerging global markets requires a balanced blend of regional regulatory insight, clinical investigator trust, and consistent on-site governance. Biopharma sponsors often face delays from complex regulatory filings, prolonged Institutional Ethics Committee (IEC) review cycles, and difficulties maintaining patient retention across multi-year trial protocols.
Through our proven clinical trial management services in India, Voxtur Clinical Research bridges sponsor objectives with ground-level trial execution. India provides a rich environment for global clinical trials—featuring world-class hospital infrastructure, English-speaking clinical investigators, high patient density, and cost-effective clinical development economics.
With more than 20 years of hands-on scientific and operational experience, our trial operations team aligns clinical workflows with the New Drugs and Clinical Trials Rules (NDCTR 2019) and global GCP standards. We ensure reliable, clean, and inspection-ready trial data for submissions to the CDSCO, US FDA, EMA, and PMDA.
From preliminary feasibility evaluations and ethics submissions to proactive risk-based monitoring and database lock, our services are engineered to keep your study on time and within budget.
Nationwide site identification and investigator qualification across Tier-1 and Tier-2 medical centers in India. We streamline clinical trial agreement (CTA) legal reviews and institutional ethics submissions to compress activation timelines.
Epidemiologically driven enrollment strategies tailored to regional demographics in India. We deploy culturally aligned, multilingual patient support and engagement workflows that reduce dropout rates throughout long-term studies.
Centralized and on-site field monitoring aligning with ICH GCP E6 (R2). Our CRAs maintain thorough source data verification, proactive protocol deviation tracking, and continuous patient safety signal oversight.
Expert liaison with the Central Drugs Standard Control Organization (CDSCO) via the SUGAM portal. We manage Form CT-04/06 clinical trial permits, import/test licenses (Form CT-11/17), and Subject Expert Committee (SEC) presentations.
Complete clinical drug supply oversight across India, including validated cold-chain shipping (2°C–8°C / -20°C / -80°C), depot management, local site accountability, randomized kit dispensing, and compliant destruction.
Electronic Data Capture (EDC) setup, medical coding (MedDRA, WHO-DD), double-programming validation, and CDISC SDTM/ADaM standardization for rapid, audit-ready database lock and clinical study report (CSR) delivery.
Direct partnerships with accredited academic medical universities, multi-specialty private hospital chains, and dedicated oncology centers across North, South, West, and East India.
Comprehensive command of the New Drugs and Clinical Trials Rules (NDCTR 2019), audio-video informed consent mandates, and compensatory guidelines for study-related injuries.
An autonomous internal QA division conducts routine investigator site audits and vendor qualifications, ensuring your trial master file (TMF) is always prepared for regulatory inspection.
Clear, milestone-based cost frameworks designed to eliminate unexpected budget expansions and maximize return on research capital for emerging biotechs and enterprise sponsors.
Our operational model is built around clear milestones, risk-based surveillance, and transparent communication between sponsors, sites, and regulatory bodies.
Comprehensive site profiling, investigator selection, patient density assessment, and protocol optimization tailored to Indian medical practice patterns.
Ethics committee dossier submissions, investigator brochure distribution, regional language translations, CTA finalization, and formal Site Initiation Visits (SIVs).
Active recruitment management, CRA on-site and remote monitoring visits, IP accountability tracking, and expedited 24-hour SAE safety reporting.
Query resolution, complete Trial Master File reconciliation, close-out visits, statistical analysis execution, and ICH E3 Clinical Study Report compilation.
India represents one of the most dynamic clinical research destinations globally. With a population exceeding 1.4 billion and a broad spectrum of lifestyle and infectious diseases, the country offers unparalleled access to treatment-naive subject populations across virtually every therapeutic indication.
Under the New Drugs and Clinical Trials Rules (2019), India’s regulatory framework has matured into a predictable, transparent, and clearly defined pathway. Defined timelines for CDSCO approvals, stable Ethics Committee oversight, and strict adherence to ICH-GCP standards provide international sponsors with confidence in data validity and ethical subject protection.
Voxtur Clinical Research provides the ground-level operational leadership needed to navigate this vast landscape—delivering reliable execution, high recruitment velocity, and cost advantages without sacrificing scientific quality.
Trial success requires deep familiarity with disease-specific standard-of-care differences, local diagnostic pathways, and specialized endpoints. Our clinical team has managed trials across high-demand therapeutic areas:
Build a unified clinical research program with Voxtur’s specialized clinical, regulatory, and analytical divisions.
Collaborate with a clinical research organization that pairs local execution capability with global regulatory quality. Share your protocol synopsis or study requirements with our clinical operations experts today.